An overview of key players in the market Filed Under: Metabolic disease/endicrinology Tagged With: biotech acquisitions, diabetes medications, drug pipelines, GLP-1, Novo Nordisk, obesity drugs, Wegovy Brian Buntz As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2B media, with a focus on healthcare and technology
On days 5 and 12 of the BM assay short-term memory (STM) and long-term memory (LTM), respectively, were tested, evaluating how well the mice remembered the location of the target hole
Most of the evidence suggesting that GLP-1 medications helped quiet food noise was anecdotal until recently
Consider whether you're meeting physical activity recommendations (at least 150 minutes of moderate-intensity activity weekly)
All our vials arrive in the lyophilized (powdered) form and must be reconstituted with bacteriostatic water prior to research use
Results from treatments may vary between individuals, and no guarantees are made regarding outcomes